Infectious disease researchers found the vaccine, used to prevent herpes zoster, or shingles, is also linked to lower risks ...
Entrepreneur Ali Fedotowsky-Manno opens up about her unexpected shingles diagnosis at 36 and her husband’s thyroid cancer in ...
Incyte (Nasdaq:INCY) today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura ® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who ...
New research reveals the shingles vaccine may cut vascular dementia risk by half, offering unexpected brain protection beyond ...
The vaccine is intended to prevent a painful rash, but experts say it does way more than that. Ford doubles down on Reagan ad ...
Several observational analyses suggest higher cardiovascular and dementia risks in those with and without HIV who get ...
The China National Medical Products Administration (NMPA) has approved Shingrix (GSK's Recombinant Zoster Vaccine or RZV) for ...
Results of a recent study show adults with cardiovascular disease (CVD) have an increased risk of contracting shingles.
Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...
LEO Pharma A/S, a global leader in medical dermatology, is advancing the understanding of skin disease and its impact on patients' lives with the presentation of 46 abstracts at the upcoming 2025 Fall ...